Obtaining endothelial colony–forming cells derived from peripheral blood is an elegant technique that allows the generation of induced pluripotent stem cells (iPSC) from PAH patients at diagnosis and from healthy bmpr2 mutation carriers [7]. Here, BMPR2 is linked to pulmonary arterial hypertension.